Clinical Trial Update: To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a single injection of GenSci094 for ovarian stimulation in infertility, using daily recombinant FSH as a r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GenSci094

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Infertility | Phase 3 | Status: COMPLETED